ASCE yields 0.21% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ASCE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASCE + JNJ for your $10,000?
ASCE is actively managed and invests primarily in equity securities of small- and medium-cap US companies, within the Russell 2500 Index range. Up to 20% of total assets may be allocated to foreign issuers in developed markets, including ADRs. The fund combines quantitative methods with qualitative analysis in selecting companies believed to be relatively undervalued with possible future earnings. The quantitative method is based on a proprietary alpha model which ranks securities based on valuation, quality, and momentum. The qualitative analysis, on the other hand, includes management evaluation, products, competition, and risk. A focused portfolio of approximately 50 securities diversified across major sectors is curated, avoiding issuers with significant alcohol, gaming, or tobacco business. Cash or money market instruments may also be held for liquidity or short-term defensive investments, which may impact the funds objectives during such periods.
Full ASCE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.